Singer Edward L MD is categorized under Internal Medicine Doctors in Chula Vista, CA and active since 1977.
Singer Edward L MD was established in 1977, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Edward Singer at the company’s single location by writing to 752 Medical Center Court # 301, Chula Vista, California CA 91911 or by phoning (619) 421-1155. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Singer Edward L MD |
| Contact Person: | Edward Singer |
| Address: | 752 Medical Center Court # 301, Chula Vista, California 91911 |
| Phone Number: | (619) 421-1155 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1977 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Singer Edward L MD was started in 1977 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Edward Singer for inquiries that concern Singer Edward L MD by calling the company number (619) 421-1155, as your correspondence is most welcome. Additionally, the physical location of the single location of Singer Edward L MD can be found at the coordinates 32.618978,-117.024989 as well as the street address 752 Medical Center Court # 301 in Chula Vista, California 91911.
For its online presence, you may visit Singer Edward L MD’s website at and engage with its social media outlets through on Twitter and on Facebook.